Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy
Public ClinicalTrials.gov record NCT00160173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy Study Comparing 0.9 g and 1.25 g EstroGel® 0.03% Doses With Placebo in the Treatment of Vasomotor Symptoms and Vulvar and Vaginal Atrophy Associated With Menopause
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is intended to establish the lowest effective dose of EstroGel® for the treatment of vasomotor symptoms associated with menopause.
Study identification
- NCT ID
- NCT00160173
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 221 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2, 2004 (Actual)
- Primary completion
- Sep 6, 2005 (Actual)
- Completion
- Sep 6, 2005 (Actual)
- Last update posted
- Sep 13, 2022
2004 – 2005
United States locations
- U.S. sites
- 109
- U.S. states
- 32
- U.S. cities
- 81
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 112 | Birmingham | Alabama | — | — |
| Site 74 | Mobile | Alabama | — | — |
| Site 20 | Montgomery | Alabama | — | — |
| Site 34 | Tucson | Arizona | — | — |
| Site 68 | Tucson | Arizona | — | — |
| Site 5 | Jonesboro | Arkansas | — | — |
| Site 88 | Little Rock | Arkansas | — | — |
| Site 95 | Little Rock | Arkansas | — | — |
| Site 104 | Carmichael | California | — | — |
| Site 42 | Encinitas | California | — | — |
| Site 21 | San Diego | California | — | — |
| Site 37 | San Diego | California | — | — |
| Site 78 | San Diego | California | — | — |
| Site 82 | San Diego | California | — | — |
| Site 69 | Avon | Connecticut | — | — |
| Site 58 | Bridgeport | Connecticut | — | — |
| Site 3 | Groton | Connecticut | — | — |
| Site 72 | Hartford | Connecticut | — | — |
| Site 54 | New Britain | Connecticut | — | — |
| Site 79 | Southport | Connecticut | — | — |
| Site 18 | Waterbury | Connecticut | — | — |
| Site 97 | West Hartford | Connecticut | — | — |
| Site 35 | Aventura | Florida | — | — |
| Site 36 | Aventura | Florida | — | — |
| Site 105 | Clearwater | Florida | — | — |
| Site 49 | Clearwater | Florida | — | — |
| Site 91 | Daytona Beach | Florida | — | — |
| Site 57 | Melbourne | Florida | — | — |
| Site 109 | Miami | Florida | — | — |
| Site 39 | Pinellas Park | Florida | — | — |
| Site 107 | Spring Hill | Florida | — | — |
| Site 100 | Tampa | Florida | — | — |
| Site 77 | West Palm Beach | Florida | — | — |
| Site 61 | Alpharetta | Georgia | — | — |
| Site 81 | Alpharetta | Georgia | — | — |
| Site 28 | Atlanta | Georgia | — | — |
| Site 93 | Atlanta | Georgia | — | — |
| Site 55 | Decatur | Georgia | — | — |
| Site 13 | Douglasville | Georgia | — | — |
| Site 87 | Powder Springs | Georgia | — | — |
| Site 22 | Savannah | Georgia | — | — |
| Site 99 | Savannah | Georgia | — | — |
| Site 53 | Boise | Idaho | — | — |
| Site 96 | Champaign | Illinois | — | — |
| Site 24 | Chicago | Illinois | — | — |
| Site 84 | Chicago | Illinois | — | — |
| Site 26 | Peoria | Illinois | — | — |
| Site 46 | Peoria | Illinois | — | — |
| Site 75 | Evansville | Indiana | — | — |
| Site 45 | South Bend | Indiana | — | — |
| Site 8 | Waterloo | Iowa | — | — |
| Site 108 | Lexington | Kentucky | — | — |
| Site 50 | Baton Rouge | Louisiana | — | — |
| Site 12 | Metairie | Louisiana | — | — |
| Site 65 | New Orleans | Louisiana | — | — |
| Site 16 | Shreveport | Louisiana | — | — |
| Site 11 | Baltimore | Maryland | — | — |
| Site 66 | Ann Arbor | Michigan | — | — |
| Site 15 | Chaska | Minnesota | — | — |
| Site 29 | Creve Coeur | Missouri | — | — |
| Site 2 | St Louis | Missouri | — | — |
| Site 67 | St Louis | Missouri | — | — |
| Site 19 | Billings | Montana | — | — |
| Site 56 | Lincoln | Nebraska | — | — |
| Site 6 | Las Vegas | Nevada | — | — |
| Site 40 | Reno | Nevada | — | — |
| Site102 | Olean | New York | — | — |
| Site 31 | Fayetteville | North Carolina | — | — |
| Site 60 | New Bern | North Carolina | — | — |
| Site 59 | Raleigh | North Carolina | — | — |
| Site 38 | Winston-Salem | North Carolina | — | — |
| Site 70 | Winston-Salem | North Carolina | — | — |
| Site 85 | Winston-Salem | North Carolina | — | — |
| Site 86 | Cincinnati | Ohio | — | — |
| Site 101 | Edmond | Oklahoma | — | — |
| Site 89 | Eugene | Oregon | — | — |
| Site 111 | Medford | Oregon | — | — |
| Site 64 | Portland | Oregon | — | — |
| Site 113 | Erie | Pennsylvania | — | — |
| Site 98 | Pottstown | Pennsylvania | — | — |
| Site 33 | Greenville | South Carolina | — | — |
| Site 9 | Chattanooga | Tennessee | — | — |
| Site 92 | Memphis | Tennessee | — | — |
| Site 76 | Nashville | Tennessee | — | — |
| Site 83 | Carrollton | Texas | — | — |
| Site 17 | Conroe | Texas | — | — |
| Site 23 | Corpus Christi | Texas | — | — |
| Site 25 | Corpus Christi | Texas | — | — |
| Site 30 | Dallas | Texas | — | — |
| Site 90 | Dallas | Texas | — | — |
| Site 10 | Houston | Texas | — | — |
| Site 110 | Houston | Texas | — | — |
| Site 14 | Houston | Texas | — | — |
| Site 27 | Houston | Texas | — | — |
| Site 48 | Houston | Texas | — | — |
| Site 51 | Houston | Texas | — | — |
| Site 71 | Houston | Texas | — | — |
| Site 73 | Houston | Texas | — | — |
| Site 43 | San Antonio | Texas | — | — |
| Site 62 | San Antonio | Texas | — | — |
| Site 80 | San Antonio | Texas | — | — |
| Site 7 | Texarkana | Texas | — | — |
| Site 44 | Salt Lake City | Utah | — | — |
| Site 94 | Salt Lake City | Utah | — | — |
| Site 47 | Norfolk | Virginia | — | — |
| Site 106 | Richmond | Virginia | — | — |
| Site 41 | Richmond | Virginia | — | — |
| Site 4 | Seattle | Washington | — | — |
| Site 52 | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00160173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 13, 2022 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00160173 live on ClinicalTrials.gov.